Treatment to regulate the gut microbiota

摘要

The present invention is directed to the regulation of intestinal flora. Specifically, the present invention relates to pharmaceutical compositions for use in the recovery of gastrointestinal homeostasis and the reduction of gastrointestinal disorders and other conditions associated with intestinal flora imbalances. More specifically, the present invention relates to the use of a composition comprising a therapeutically effective amount of a fatty acid bile acid conjugate (FABAC). [Selection figure] None